Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Jan;79(1):59-64.
doi: 10.1172/JCI112808.

Complementation analysis of fatty acid oxidation disorders

Complementation analysis of fatty acid oxidation disorders

A Moon et al. J Clin Invest. 1987 Jan.

Abstract

We assayed [9,10(n)-3H]palmitate oxidation by fibroblast monolayers from patients with fatty acid oxidation disorders. Activities in the different disorders were (percent control): short-chain acyl-coenzyme A (CoA) dehydrogenase deficiency (115%), medium chain acyl-CoA dehydrogenase deficiency (18%), long-chain acyl-CoA dehydrogenase deficiency (28%), multiple acyl-CoA dehydrogenation disorder, mild and severe variants (49% and 7%), and palmityl-carnitine transferase deficiency (4%). Multiple acyl-CoA dehydrogenation disorder, medium chain acyl-CoA dehydrogenase-deficient lines, and long-chain acyl-CoA dehydrogenase-deficient lines all complemented one another after polyethylene glycol fusion, with average activity increases of 31-83%. We detected two complementation groups in the severe multiple acyl-CoA dehydrogenation disorder lines, consistent with deficiencies of either electron transfer flavoprotein or electron transfer flavoprotein:ubiquinone oxidoreductase. The metabolic block in the latter cell lines is threefold more severe than in the former (P less than 0.001). No intragenic complementation was observed within either group. We assigned two patients with previously unreported severe multiple acyl-CoA dehydrogenation disorder to the electron transfer flavoprotein:ubiquinone oxido-reductase-deficient group.

PubMed Disclaimer

References

    1. Arch Biochem Biophys. 1973 Mar;155(1):213-20 - PubMed
    1. Clin Chim Acta. 1976 Jan 16;66(2):227-39 - PubMed
    1. J Clin Invest. 1979 Dec;64(6):1580-9 - PubMed
    1. N Engl J Med. 1979 Dec 27;301(26):1405-9 - PubMed
    1. J Inherit Metab Dis. 1980;3(3):67-72 - PubMed

Publication types

MeSH terms